From Reuters.

Denmark’s Novo Nordisk launched a rival bid for US obesity biotech firm Metsera, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative weight-loss drug market.

#News #Reuters #Newsfeed #novonordisk #pfizer #metsera #weightlossdrugs

Read the story here: https://reut.rs/47C2RHf

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en